|
|
Volumn 1, Issue 3, 2006, Pages 207-215
|
|
The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
TAMOXIFEN;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
QUALITY OF LIFE;
TAMOXIFEN;
TREATMENT OUTCOME;
|
|
EID: 44849131025
PISSN: 15748871
EISSN: None
Source Type: Journal
DOI: 10.2174/157488706778250096 Document Type: Review |
|
Times cited : (11)
|
|
References (42)
|
